When conducting cardiovascular clinical trials, it is important to work with a Cardiology CRO that has a strong track record in cardiovascular research. Vial CRO team has decades of experience in this field and has accumulate data from hundreds of thousands of participants around the world.
The company uses electronic reporting technologies to track study progress and ensure patient compliance. This allows study stakeholders to intervene in the early stages of any potential problem. Moreover, Vial CRO offers the strength of a Cardiology CRO with the personal touch of a team commit to the success of the study.
Among the major benefits of working with Vial CRO is its ability to reduce the administrative burdens of sponsoring trials by reducing the number of duplicate notifications. Additionally, the company’s safety and pharmacological reporting capabilities are streamlined by the use of its proprietary technology solutions. These solutions include WCG Safety Vigilance and Investigator Space.
Vial CRO was find by Dr. Cutler in 1994. Cardiology CRO Company has been recognize for pioneering many new techniques in drug development and has an extensive portfolio of services focus on cardiovascular and central nervous system diseases. Its team has a wealth of experience in the field and helps clients think through all phases of their research.
Teree Olson, MD, is an expert in cardiovascular disease and a member of the BHF Regenerative Medicine Initiative and the Cardiovascular Genomics England Clinical Interpretation Panel. She has been active in the medical community, serving on the CSI foundation’s Emerging Leaders Mentor program and the CSI Foundation’s social media team. Her expertise and commitment to quality patient care make her one of the most highly sought after Cardiologists in the field.
Senior Vice President of Project Management for the Cardio metabolic Franchise at Worldwide Clinical Trials, Karen Hill, has more than 25 years of experience in project management. Karen oversees global teams of project managers and Clinical Research Associate (CRA) staff on cardio-metabolic outcome mega-studies, observational studies, and other clinical trials.
Karen’s experience also includes negotiation of study budgets, site contracts, and communications associate with trial meetings. She also helps to ensure that each trial is execute according to MMRCC start-up and enrollment benchmarks and works closely with the investigators and project managers at consortium sites. Karen also enjoys assisting with trials and working closely with investigators and project managers.
Read also: Contract Research Organization List
When launching a cardiovascular clinical trial, it is critical to work with an experience and specialize Cardiology CRO. IQVIA brings unmatch experience, agility, and data-driven analytics to cardiovascular clinical trials of all sizes. From small trials to large trials, IQVIA’s cardiovascular team is prepare for any challenge.
IQVIA helps hundreds of companies, universities, and governments worldwide develop and execute clinical trials. Its services help accelerate drug development and ensure high product quality. It`s clinical experts help improve trial efficiency, reduce risk, and accelerate access to life-changing therapies faster. It is standardize, flexible solutions help reduce costs and risks while delivering high-quality research results.
IQVIA is one of the largest CROs in the world. Found in 1982, it has grow into an international company with offices in more than 100 countries. IQVIA is headquarter in Durham, North Carolina, and has more than 88,000 employees worldwide. Its subsidiary Parexel is a global clinical research organization that conducts research for pharmaceutical partners. With operations in more than 100 countries, IQVIA has a diverse portfolio of clinical research services.
IQVIA’s services are available in all major countries. The organization has extensive networks of investigators and sites across the world. Its global presence makes it an effective choice for large global clinical trials. Its research teams operate across multiple countries to ensure the safety and efficacy of new drugs.
CROMSOURCE is an international contract research organization that provides a comprehensive range of services to the biotechnology, pharmaceutical and medical device industries. The company was founded in 1997 and has a reputation for high standards, integrity, and client satisfaction. It has offices throughout Europe and North America. The company’s dedicated staff have extensive experience and expertise in a wide range of clinical research services.
CROMSOURCE has a proven track record in delivering clinical research projects and has experience working on large, international pivotal trials. It has also successfully managed registry studies with large datasets. In addition, it has similar experience with projects involving medical devices, such as cardiac valves, drug elating stents, and vascular imaging media.
CROMSOURCE’s team is led by Dr. Dyson, who has over 20 years of experience in clinical research, working in a variety of roles within the industry. She has held key positions in CROMSOURCE and has helped shape the direction of the company. Prior to joining CROMSOURCE, she held an executive role at Catalyst Pharma Group, where she focused on corporate development activities.
Medical devices are an increasingly complicated and demanding field, and CROs are growing in numbers to meet the demand. Currently, more than 300 CROs provide contract services for the development of medical devices. These services encompass clinical operations management, data management, regulatory services, and quality assurance.